Ignite Creation Date:
2024-05-06 @ 8:01 AM
Last Modification Date:
2024-10-26 @ 11:55 AM
Study NCT ID:
NCT02650531
Status:
COMPLETED
Last Update Posted:
2022-02-23
First Post:
2015-12-10
Brief Title:
Norwegian COgnitive Impairment After STroke NorCOAST Study
Sponsor:
Norwegian University of Science and Technology
Organization:
Norwegian University of Science and Technology
Study Overview
Official Title:
Norwegian COgnitive Impairment After STroke NorCOAST Study
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Nor-Coast
Brief Summary:
A prospective observational multicenter study aiming to describe incidence and identify predictors for development of poststroke dementia PSD and mild cognitive impairment MCI after stroke
Detailed Description:
About 15000 Norwegians suffer a stroke every year and 23 will be more or less disabled In addition to motor impairments and comorbidities disability after stroke is often related to post stroke dementia PSD or mild neurocognitive disorder NCD However these problems are hardly addressed in stroke or dementia research and frequently ignored in clinical practise In the Nor-COAST study an interdisciplinary research group will collaborate to establish a research platform across all Norwegian Health Authorities The overall aim of the study is to improve competence on PSD and NCD in order to improve individual health outcomes following a stroke The specific objectives are to determine the incidence of PSD and NCD and the consequences on function and use of health care services and to enhance the early detection of PSD and NCD by identifying a set of risk factors ranging from genetics to physical activity The incidence and impact of PSD and NCD on function and use of health care services medication and life-style changes are important when planning future health care services Tools identifying patients at risk might improve diagnostic work up and together with knowledge on pathogenic aspects it will contribute to future treatment and prevention of PSD and NCD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None